EUVIMEDEUVIMED entdecken
Crossref

X-linked hypophosphatemic rickets. What the orthopedic surgeon needs to know

Annalisa De Cicco, Giuseppe Toro, Anna Grandone, Adriano Braile, Giovanni Landi, Giovanni Iolascon, Emanuele Miraglia Del Giudice, Alfredo Schiavone Panni

International Journal of Bone Fragility · 2021

DOI: 10.57582/ijbf.210102.059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Bone Fragility, 2021. Verfasst von Annalisa De Cicco und 7 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

X-linked hypophosphatemic rickets (XLH) is a rare genetic disease characterized by an increase in fibroblast growth factor 23 (FGF23) expression. The skeleton is one of the systems most affected and deformities of the lower limbs are one of the first reasons for consulting an orthopedic surgeon. The aim of the present study was to offer practical advice for a comprehensive orthopedic approach to XLH. Materials: A literature search was conducted in PubMed, a freely available and cost-effective database. The articles included in the study were discussed by a research group with specific expertise in bone metabolism and pediatric deformities, in order to answer three fundamental questions and thus provide the orthopedic specialist with guidance on XLH: (1) How should the physician complete the diagnosis of XLH?; (2) When might a surgical procedure be recommended?; (3) What kind of surgical procedure should be performed?

Results

Sixty-three articles were included and discussed by the research group.

Conclusions

A correct and timely diagnosis of XLH is essential to appropriately manage affected patients. To complete this diagnosis a detailed medical history of the patient, a comprehensive clinical and radiographic evaluation, and specific biochemical tests are needed. Pharmacological treatment is based on supplementation of both phosphate and vitamin D, however, a monoclonal antibody that inactivates FGF23 (burosumab), has recently been introduced with promising results. Orthopedic surgery is needed in cases of moderate or severe deformities, to allow physiological growth and prevent early osteoarthritis and gait alterations. Surgical options are osteotomies and hemiepiphysiodesis, which is preferred whenever possible. Three different devices for temporary hemiepiphysiodesis are available (staples, transphyseal screws and tension band plates). Obviously, surgical procedures need an appropriate medical therapy to be effective. In conclusion, the diagnosis, treatment and follow-up of XLH require a multidisciplinary approach and a comprehensive evaluation of anamnestic, clinical and radiographic data.

Zitieren

APA

Cicco, A. D., Toro, G., Grandone, A., Braile, A., Landi, G., Iolascon, G., Giudice, E. M. D., & Panni, A. S. (2021). X-linked hypophosphatemic rickets. What the orthopedic surgeon needs to know. International Journal of Bone Fragility. https://doi.org/10.57582/ijbf.210102.059

Vancouver

Cicco AD, Toro G, Grandone A, Braile A, Landi G, Iolascon G, et al. X-linked hypophosphatemic rickets. What the orthopedic surgeon needs to know. International Journal of Bone Fragility. 2021. doi:10.57582/ijbf.210102.059

BibTeX
@article{Cicco2021,
  author = {Cicco, Annalisa De and Toro, Giuseppe and Grandone, Anna and Braile, Adriano and Landi, Giovanni and Iolascon, Giovanni and Giudice, Emanuele Miraglia Del and Panni, Alfredo Schiavone},
  title = {X-linked hypophosphatemic rickets. What the orthopedic surgeon needs to know},
  journal = {International Journal of Bone Fragility},
  year = {2021},
  doi = {10.57582/ijbf.210102.059}
}
Kostenlos starten →